22nd Century Group, Inc. (XXII): A Promising Company in the Tobacco Industry
Buffalo, NY – 22nd Century Group, Inc. (XXII) is an agricultural biotechnology company that focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science. The company is at the forefront of developing very low nicotine content tobacco and cigarette products. It also collaborates with Keygene N.V. to develop hemp/cannabis plants for medical, therapeutic, and agricultural uses.
Financial Performance and Outlook
Despite the challenges faced by the tobacco industry, 22nd Century Group, Inc. has shown resilience and is poised for growth. The company's revenue for the last fiscal year was $83.7 million, with a revenue growth rate of -2.4%. The company has a market capitalization of $5.75 million and a book value of $0.654 per share.
Support authors and subscribe to content
This is premium content. Subscribe to read the entire article.
